Estrogen-related receptor α (ERRα) and ERRγ are essential coordinators of cardiac metabolism and function

Molecular and Cellular Biology

Volumn 35, Issue 7, 2015, Pages 1281-1298

  Wang, Ting ^a   McDonald, Caitlin ^a   Petrenko, Nataliya B ^b,f   Leblanc, Mathias ^c   Wang, Tao ^b   Giguere, Vincent ^d   Evans, Ronald M ^e   Patel, Vickas V ^b,f   Pei, Liming ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL CACNA1C; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR GAMMA; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL KCNJ2; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL NAV1.5; STEROID RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL BETA 4 SUBUNIT; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESRRG PROTEIN, MOUSE; ESTROGEN RECEPTOR; ION CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CELL ENERGY; CELL FUNCTION; CELL METABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; ENERGY CONSUMPTION; ENERGY YIELD; FEMALE; GENE EXPRESSION; HEART CONDUCTION; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART REPOLARIZATION; HEART WEIGHT; MALE; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MOUSE; NONHUMAN; PERINATAL PERIOD; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART MITOCHONDRION; HEART MUSCLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; CARDIOMYOPATHIES; CELLS, CULTURED; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; HEART; ION CHANNELS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; RECEPTORS, ESTROGEN;

EID: 84924856927     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01156-14     Document Type: Article

References (71)

1. Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell 104:531-543. http://dx.doi.org/10.1016/S0092-8674(01)00240-9.
2. Huss JM, Kelly DP. 2005. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 115:547-555. http://dx.doi.org/10.1172/JCI24405.
3. Cortassa S, Aon MA, O'Rourke B, Jacques R, Tseng HJ, Marban E, Winslow RL. 2006. A computational model integrating electrophysiology, contraction, and mitochondrial bioenergetics in the ventricular myocyte. Biophys J 91:1564-1589. http://dx.doi.org/10.1529/biophysj.105.076174.
4. Kane LA, Youle RJ. 2010. Mitochondrial fission and fusion and their roles in the heart. J Mol Med (Berl) 88:971-979. http://dx.doi.org/10.1007/s00109-010-0674-6.
5. Jafri MS, Dudycha SJ, O'Rourke B. 2001. Cardiac energy metabolism: models of cellular respiration. Annu Rev Biomed Eng 3:57-81. http://dx.doi.org/10.1146/annurev.bioeng.3.1.57.
6. Wallace DC. 2000. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J 139:S70-85. http://dx.doi.org/10.1067/mhj.2000.103934.
7. Griffiths EJ. 2012. Mitochondria and heart disease. Adv Exp Med Biol 942:249-267. http://dx.doi.org/10.1007/978-94-007-2869-1_11.
8. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. 2010. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192667.
9. Harvey PA, Leinwand LA. 2011. The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol 194:355-365. http://dx.doi.org/10.1083/jcb.201101100.
10. Evans R. 2004. A transcriptional basis for physiology. Nat Med 10:1022-1026. http://dx.doi.org/10.1038/nm1004-1022.
11. Sonoda J, Pei L, Evans RM. 2008. Nuclear receptors: decoding metabolic disease. FEBS Lett 582:2-9. http://dx.doi.org/10.1016/j.febslet.2007.11.016.
12. Evans RM, Mangelsdorf DJ. 2014. Nuclear receptors, RXR, and the BIG Bang. Cell 157:255-266. http://dx.doi.org/10.1016/j.cell.2014.03.012.
13. Huss JM, Kelly DP. 2004. Nuclear receptor signaling and cardiac energetics. Circ Res 95:568-578. http://dx.doi.org/10.1161/01.RES.0000141774.29937.e3.
14. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP. 2005. PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3:e101. http://dx.doi.org/10.1371/journal.pbio.0030101.
15. Burkart EM, Sambandam N, Han X, Gross RW, Courtois M, Gierasch CM, Shoghi K, Welch MJ, Kelly DP. 2007. Nuclear receptors PPARß/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest 117:3930-3939. http://dx.doi.org/10.1172/JCI32578.
16. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM. 2005. Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle. Cell Metab 1:259-271. http://dx.doi.org/10.1016/j.cmet.2005.03.002.
17. Giguere V. 2008. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 29:677-696. http://dx.doi.org/10.1210/er.2008-0017.
18. Villena JA, Kralli A. 2008. ERRα: a metabolic function for the oldest orphan. Trends Endocrinol Metab 19:269-276. http://dx.doi.org/10.1016/j.tem.2008.07.005.
19. Eichner LJ, Giguere V. 2011. Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11:544-552. http://dx.doi.org/10.1016/j.mito.2011.03.121.
20. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, Evans RM, Blanchette M, Giguere V. 2007. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRα and γ. Cell Metab 5:345-356. http://dx.doi.org/10.1016/j.cmet.2007.03.007.
21. Huss JM, Imahashi K, Dufour CR, Weinheimer CJ, Courtois M, Kovacs A, Giguere V, Murphy E, Kelly DP. 2007. The nuclear receptor ERRα is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab 6:25-37. http://dx.doi.org/10.1016/j.cmet.2007.06.005.
22. Alaynick WA, Kondo RP, Xie W, He W, Dufour CR, Downes M, Jonker JW, Giles W, Naviaux RK, Giguere V, Evans RM. 2007. ERRγ directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab 6:13-24. http://dx.doi.org/10.1016/j.cmet.2007.06.007.
23. Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguere V. 2003. Reduced fat mass in mice lacking orphan nuclear receptor estrogenrelated receptor alpha. Mol Cell Biol 23:7947-7956. http://dx.doi.org/10.1128/MCB.23.22.7947-7956.2003.
24. Gan Z, Rumsey J, Hazen BC, Lai L, Leone TC, Vega RB, Xie H, Conley KE, Auwerx J, Smith SR, Olson EN, Kralli A, Kelly DP. 2013. Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. J Clin Invest 123:2564-2575. http://dx.doi.org/10.1172/JCI67652.
25. Wang T, Yu Q, Chen J, Deng B, Qian L, Le Y. 2010. PP2A mediated AMPK inhibition promotes HSP70 expression in heat shock response. PLoS One 5:e13096. http://dx.doi.org/10.1371/journal.pone.0013096.
26. Pei L, Leblanc M, Barish G, Atkins A, Nofsinger R, Whyte J, Gold D, He M, Kawamura K, Li HR, Downes M, Yu RT, Powell HC, Lingrel JB, Evans RM. 2011. Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat Med 17:1466-1472. http://dx.doi.org/10.1038/nm.2450.
27. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. 2006. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12:1048-1055. http://dx.doi.org/10.1038/nm1471.
28. Wang T, Yanger K, Stanger BZ, Cassio D, Bi E. 2014. Cytokinesis defines a spatial landmark for hepatocyte polarization and apical lumen formation. J Cell Sci 127:2483-2492. http://dx.doi.org/10.1242/jcs.139923.
29. Wang D, Patel VV, Ricciotti E, Zhou R, Levin MD, Gao E, Yu Z, Ferrari VA, Lu MM, Xu J, Zhang H, Hui Y, Cheng Y, Petrenko N, Yu Y, FitzGerald GA. 2009. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc Natl Acad Sci U S A 106:7548-7552. http://dx.doi.org/10.1073/pnas.0805806106.
30. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD. 1997. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179.
31. Boomsma F, van den Meiracker AH. 2001. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 51:442-449. http://dx.doi.org/10.1016/S0008-6363(01)00195-X.
32. Maisel A. 2001. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 19:557-571. http://dx.doi.org/10.1016/S0733-8651(05)70243-5.
33. Chen H, McCaffery JM, Chan DC. 2007. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130:548-562. http://dx.doi.org/10.1016/j.cell.2007.06.026.
34. Okamoto K, Shaw JM. 2005. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu Rev Genet 39:503-536. http://dx.doi.org/10.1146/annurev.genet.38.072902.093019.
35. Suen DF, Norris KL, Youle RJ. 2008. Mitochondrial dynamics and apoptosis. Genes Dev 22:1577-1590. http://dx.doi.org/10.1101/gad.1658508.
36. Westermann B. 2010. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 11:872-884. http://dx.doi.org/10.1038/nrm3013.
37. Schneeberger M, Dietrich MO, Sebastian D, Imbernon M, Castano C, Garcia A, Esteban Y, Gonzalez-Franquesa A, Rodriguez IC, Bortolozzi A, Garcia-Roves PM, Gomis R, Nogueiras R, Horvath TL, Zorzano A, Claret M. 2013. Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. Cell 155:172-187. http://dx.doi.org/10.1016/j.cell.2013.09.003.
38. Liesa M, Shirihai OS. 2013. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab 17:491-506. http://dx.doi.org/10.1016/j.cmet.2013.03.002.
39. Dietrich MO, Liu ZW, Horvath TL. 2013. Mitochondrial dynamics controlled by mitofusins regulate Agrp neuronal activity and diet-induced obesity. Cell 155:188-199. http://dx.doi.org/10.1016/j.cell.2013.09.004.
40. Liesa M, Palacin M, Zorzano A. 2009. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89:799-845. http://dx.doi.org/10.1152/physrev.00030.2008.
41. Chan DC. 2012. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 46:265-287. http://dx.doi.org/10.1146/annurev-genet-110410-132529.
42. Dorn GW, II. 2013. Mitochondrial dynamics in heart disease. Biochim Biophys Acta 1833:233-241. http://dx.doi.org/10.1016/j.bbamcr.2012.03.008.
43. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, Chan DC. 2010. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141:280-289. http://dx.doi.org/10.1016/j.cell.2010.02.026.
44. Papanicolaou KN, Kikuchi R, Ngoh GA, Coughlan KA, Dominguez I, Stanley WC, Walsh K. 2012. Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res 111:1012-1026. http://dx.doi.org/10.1161/CIRCRESAHA.112.274142.
45. Chen Y, Liu Y, Dorn GW, II. 2011. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 109:1327-1331. http://dx.doi.org/10.1161/CIRCRESAHA.111.258723.
46. Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, Mihara K. 2010. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol 191:1141-1158. http://dx.doi.org/10.1083/jcb.201007152.
47. Martin OJ, Lai L, Soundarapandian MM, Leone TC, Zorzano A, Keller MP, Attie AD, Muoio DM, Kelly DP. 2014. A role for PGC-1 coactivators in the control of mitochondrial dynamics during postnatal cardiac growth. Circ Res 114:626-636. http://dx.doi.org/10.1161/CIRCRESAHA.114.302562.
48. Nass RD, Aiba T, Tomaselli GF, Akar FG. 2008. Mechanisms of disease: ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovasc Med 5:196-207. http://dx.doi.org/10.1038/ncpcardio1130.
49. Alaynick WA, Way JM, Wilson SA, Benson WG, Pei L, Downes M, Yu R, Jonker JW, Holt JA, Rajpal DK, Li H, Stuart J, McPherson R, Remlinger KS, Chang CY, McDonnell DP, Evans RM, Billin AN. 2010. ERRγ regulates cardiac, gastric, and renal potassium homeostasis. Mol Endocrinol 24:299-309. http://dx.doi.org/10.1210/me.2009-0114.
50. Nattel S, Maguy A, Le Bouter S, Yeh YH. 2007. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87:425-456. http://dx.doi.org/10.1152/physrev.00014.2006.
51. Campuzano O, Beltran-Alvarez P, Iglesias A, Scornik F, Perez G, Brugada R. 2010. Genetics and cardiac channelopathies. Genet Med 12:260-267. http://dx.doi.org/10.1097/GIM.0b013e3181d81636.
52. Cerrone M, Priori SG. 2011. Genetics of sudden death: focus on inherited channelopathies. Eur Heart J 32:2109-2118. http://dx.doi.org/10.1093/eurheartj/ehr082.
53. Bokil NJ, Baisden JM, Radford DJ, Summers KM. 2010. Molecular genetics of long QT syndrome. Mol Genet Metab 101:1-8. http://dx.doi.org/10.1016/j.ymgme.2010.05.011.
54. Schmitt N, Grunnet M, Olesen SP. 2014. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia. Physiol Rev 94:609-653. http://dx.doi.org/10.1152/physrev.00022.2013.
55. Berry R, Harewood L, Pei L, Fisher M, Brownstein D, Ross A, Alaynick WA, Moss J, Hastie ND, Hohenstein P, Davies JA, Evans RM, FitzPatrick DR. 2011. Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla. Hum Mol Genet 20:917-926. http://dx.doi.org/10.1093/hmg/ddq530.
56. Tremblay AM, Dufour CR, Ghahremani M, Reudelhuber TL, Giguere V. 2010. Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol Endocrinol 24:22-32. http://dx.doi.org/10.1210/me.2009-0254.
57. Liesa M, Borda-d'Agua B, Medina-Gomez G, Lelliott CJ, Paz JC, Rojo M, Palacin M, Vidal-Puig A, Zorzano A. 2008. Mitochondrial fusion is increased by the nuclear coactivator PGC-1ß. PLoS One 3:e3613. http://dx.doi.org/10.1371/journal.pone.0003613.
58. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Deriaz O, Zorzano A, Gobelet C, Kralli A, Russell AP. 2005. Mitofusins 1/2 and ERRα expression are increased in human skeletal muscle after physical exercise. J Physiol 567:349-358. http://dx.doi.org/10.1113/jphysiol.2005.092031.
59. Soriano FX, Liesa M, Bach D, Chan DC, Palacin M, Zorzano A. 2006. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-γ coactivator-1α, estrogen-related receptor-α, and mitofusin 2. Diabetes 55:1783-1791. http://dx.doi.org/10.2337/db05-0509.
60. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Bruning JC, Kahn CR, Clayton DA, Barsh GS, Thoren P, Larsson NG. 1999. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 21:133-137. http://dx.doi.org/10.1038/5089.
61. Moore JR, Leinwand L, Warshaw DM. 2012. Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor. Circ Res 111:375-385. http://dx.doi.org/10.1161/CIRCRESAHA.110.223842.
62. Akar FG, Tomaselli GF. 2005. Conduction abnormalities in nonischemic dilated cardiomyopathy: basic mechanisms and arrhythmic consequences. Trends Cardiovasc Med 15:259-264. http://dx.doi.org/10.1016/j.tcm.2005.08.002.
63. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP, Medeiros DM, Kovacs A, Kelly DP. 2008. Transcriptional coactivators PGC-1α and PGC-lß control overlapping programs required for perinatal maturation of the heart. Genes Dev 22:1948-1961. http://dx.doi.org/10.1101/gad.1661708.
64. den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, Nolte IM, Segre AV, Holm H, Handsaker RE, Westra HJ, Johnson T, Isaacs A, Yang J, Lundby A, Zhao JH, Kim YJ, Go MJ, Almgren P, Bochud M, Boucher G, Cornelis MC, Gudbjartsson D, Hadley D, van der Harst P, Hayward C, den Heijer M, Igl W, Jackson AU, Kutalik Z, Luan J, Kemp JP, Kristiansson K, Ladenvall C, Lorentzon M, Montasser ME, Njajou OT, O'Reilly PF, Padmanabhan S, St Pourcain B, Rankinen T, Salo P, Tanaka T, Timpson NJ, Vitart V, Waite L, Wheeler W, Zhang W, Draisma HH, et al. 2013. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet 45:621-631. http://dx.doi.org/10.1038/ng.2610.
65. Lin J, Handschin C, Spiegelman BM. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361-370. http://dx.doi.org/10.1016/j.cmet.2005.05.004.
66. Gupte AA, Hamilton DJ, Cordero-Reyes AM, Youker KA, Yin Z, Estep JD, Stevens RD, Wenner B, Ilkayeva O, Loebe M, Peterson LE, Lyon CJ, Wong ST, Newgard CB, Torre-Amione G, Taegtmeyer H, Hsueh WA. 2014. Mechanical unloading promotes myocardial energy recovery in human heart failure. Circ Cardiovasc Genet 7:266-276. http://dx.doi.org/10.1161/CIRCGENETICS.113.000404.
67. Hu X, Xu X, Lu Z, Zhang P, Fassett J, Zhang Y, Xin Y, Hall JL, Viollet B, Bache RJ, Huang Y, Chen Y. 2011. AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development. Hypertension 58:696-703. http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.174128.
68. Kwon DH, Eom GH, Kee HJ, Nam YS, Cho YK, Kim DK, Koo JY, Kim HS, Nam KI, Kim KK, Lee IK, Park SB, Choi HS, Kook H. 2013. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4. J Mol Cell Cardiol 65:88-97. http://dx.doi.org/10.1016/j.yjmcc.2013.09.011.
69. Kim DK, Jeong JH, Lee JM, Kim KS, Park SH, Kim YD, Koh M, Shin M, Jung YS, Kim HS, Lee TH, Oh BC, Kim JI, Park HT, Jeong WI, Lee CH, Park SB, Min JJ, Jung SI, Choi SY, Choy HE, Choi HS. 2014. Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med 20:419-424. http://dx.doi.org/10.1038/nm.3483.
70. Patch RJ, Searle LL, Kim AJ, De D, Zhu X, Askari HB, O'Neill JC, Abad MC, Rentzeperis D, Liu J, Kemmerer M, Lin L, Kasturi J, Geisler JG, Lenhard JM, Player MR, Gaul MD. 2011. Identification of diaryl etherbased ligands for estrogen-related receptor alpha as potential antidiabetic agents. J Med Chem 54:788-808. http://dx.doi.org/10.1021/jm101063h.
71. Chaveroux C, Eichner LJ, Dufour CR, Shatnawi A, Khoutorsky A, Bourque G, Sonenberg N, Giguere V. 2013. Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycininduced nonalcoholic fatty liver. Cell Metab 17:586-598. http://dx.doi.org/10.1016/j.cmet.2013.03.003.